The Team at HealthlineMusings on Healthcare, Policy and Search
Advertisement

UCB's Cimzia Approved for Crohn's Disease

JC Jones MA RN

The FDA approved Cimzia® (certolizumab pegol) for treatment of Crohn's disease, a chronic inflammatory disease of the digestive tract on April 22, 2008. Cimzia® is a pegylated anti-tumor necrosis factor (anti-TNF) agent also known as tumor necrosis factor agonists, designed to neutralize inflammatory cytokines.

Cimzia® is effective in reducing signs and symptoms and inducing and maintaining clinical remission in patients with moderately to severely active Crohn’s disease. Patients who have had an inadequate response to conventional therapy (oral mesalamine, oral corticosteroids, and 6-mercaptopurine or azathioprine (6-MP/AZA) may benefit. Symptoms of Crohn's disease are:
        • abdominal pain
        • bleeding
        • diarrhea
        • extraintestinal manifestations (arthritis, uveitis, iritis, pyoderma gangrenosum, erythema nodosum, or spondylitis)
        • internal fistulae
        • intestinal obstruction
        • perianal disease
        • megacolon
        • weight loss
Crohn's disease is marked by cycles of flare-ups and remissions through out the patient's life. Cimzia® is manufactured by UCB Group in Brussels, Belgium. It is administered by subcutaneous injection every four weeks after initial dosing.

Thank you Hamamatu Minami Hospital Gastroenterology and IBD Clinic for use of image.

Labels: , , ,

Permalink | Email Post

0 Comments:

Post a Comment

<< Home

The Healthline Site, its content, such as text, graphics, images, search results, HealthMaps, Trust Marks, and other material contained on the Healthline Site ("Content"), its services, and any information or material posted on the Healthline Site by third parties are provided for informational purposes only. None of the foregoing is a substitute for professional medical advice, examination, diagnosis, or treatment. Always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Healthline Site. If you think you may have a medical emergency, call your doctor or 911 immediately. Please read the Terms of Service for more information regarding use of the Healthline Site.